Form D · Other Technology
BioLeap, Inc.
New Hope, PA · CIK 0001480519
Offering snapshot reported Jan 12, 2010 · SEC filing
- Reported sold
- $5M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 5, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2010 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-137695
Source: Form D, filed Jan 12, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian S. Cloudsdale | Executive |
| Stephen Davis | Executive |
| Gerald Evans | Executive |
| William Frezza | Director |
| Brenda Gavin | Director |
| John Kulp, Jr. | Director, Executive |
| David Pompliano | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
346 A Lurgan Road
New Hope, PA, 18938
New Hope, PA, 18938